NCT03615443View on ClinicalTrials.gov

Noninvasive vs. Invasive Lung Evaluation

CompletedOBSERVATIONAL
Enrollment

306

Participants

Timeline

Start Date

February 12, 2016

Primary Completion Date

November 23, 2020

Study Completion Date

November 23, 2020

Conditions
Non-Small Cell Lung Cancer
Interventions
DIAGNOSTIC_TEST

Guardant360

Guardant360 is a comprehensive, non-invasive tumor sequencing test.

Sponsors
All Listed Sponsors
lead

Guardant Health, Inc.

INDUSTRY